SCM

Stonepine Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 70.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$3.43M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1
+$272M
2
+$4.81M
3
+$3.92M
4
IKT icon
Inhibikase Therapeutics
IKT
+$2.57M
5
ACET icon
Adicet Bio
ACET
+$2.43M

Top Sells

1
+$3.74M
2
+$2.6M
3
+$2.51M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$2.28M
5
SRZN icon
Surrozen
SRZN
+$2.21M

Sector Composition

1 Healthcare 100%
2 Financials 0%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VSTM icon
1
Verastem
VSTM
$431M
$21.1M 16.68%
2,732,079
+62,047
ADMA icon
2
ADMA Biologics
ADMA
$3.71B
$13.5M 10.68%
740,000
+1,000
EOLS icon
3
Evolus
EOLS
$279M
$10.9M 8.58%
1,631,588
+95,197
ZVRA icon
4
Zevra Therapeutics
ZVRA
$503M
$5.1M 4.03%
569,088
-240,912
IKT icon
5
Inhibikase Therapeutics
IKT
$249M
$4.81M 3.81%
2,348,147
+1,613,128
ABEO icon
6
Abeona Therapeutics
ABEO
$277M
$3.74M 2.96%
709,505
+258,535
NKTR icon
7
Nektar Therapeutics
NKTR
$1.93B
$3.59M 2.84%
85,000
INDV icon
8
Indivior Pharmaceuticals
INDV
$4.09B
$3.59M 2.84%
100,000
CRBP icon
9
Corbus Pharmaceuticals
CRBP
$150M
$3.17M 2.51%
+389,916
KZIA
10
Kazia Therapeutics
KZIA
$95.8M
$3.17M 2.51%
+460,359
XOMA icon
11
Xoma
XOMA
$316M
$3.06M 2.42%
115,000
-459
VRCA icon
12
Verrica Pharmaceuticals
VRCA
$87.5M
$2.94M 2.32%
+353,669
HELP
13
Cybin Inc
HELP
$367M
$2.78M 2.2%
+339,902
TELA icon
14
TELA Bio
TELA
$38.7M
$2.78M 2.2%
2,352,032
+196,513
ACAD icon
15
Acadia Pharmaceuticals
ACAD
$4.16B
$2.67M 2.11%
100,000
-74,544
SRZN icon
16
Surrozen
SRZN
$238M
$2.57M 2.03%
113,631
-136,515
XFOR icon
17
X4 Pharmaceuticals
XFOR
$301M
$2.37M 1.88%
593,573
-462,765
AYTU icon
18
AYTU BioPharma
AYTU
$27.6M
$2.12M 1.67%
813,704
-78,151
DAWN icon
19
Day One Biopharmaceuticals
DAWN
$1.09B
$1.86M 1.47%
200,000
-447,382
ACET icon
20
Adicet Bio
ACET
$69.6M
$1.85M 1.47%
+220,011
SPRB
21
Spruce Biosciences, Inc. Common Stock
SPRB
$58.8M
$1.72M 1.36%
+19,742
HRTX icon
22
Heron Therapeutics
HRTX
$218M
$1.61M 1.27%
1,237,802
+387,702
ENTA icon
23
Enanta Pharmaceuticals
ENTA
$415M
$1.58M 1.25%
100,000
-205,000
PMVP icon
24
PMV Pharmaceuticals
PMVP
$90.5M
$1.44M 1.14%
1,150,759
-219,380
CAMP icon
25
CAMP4 Therapeutics
CAMP
$233M
$1.4M 1.11%
+228,894
1
2 3 4